A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

Researchers say the catalog has already led to the identification of genetic mechanisms involved in kidney cancer and will ...

One key finding is that deleting CDKN1B, a cell cycle regulator, increased CAR T cell proliferation and improved therapy persistence.

UNIVERSITY CITY (WPVI) -- The first attempt in the United States to use a gene-editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it's too soon to ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...

Natural killer (NK) cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on CRISPR ...